# locus	type	ref	length	genotype	filter	pvalue	phred_qual_score	cnv_pvalue	coverage	allele_coverage	allele_ratio	allele_frequency_%	allele_frequency_%_corrected	zygosity	entry_count	maf	hrun	som_pval	gene	transcript	location	function	codon	exon	protein	coding	sift	polyphen	grantham	normalizedAlt	5000Exomes	FATHMM	NamedVariants	clinvar	cosmic	dbsnp	dgv	dra	drugbank	go	omim	pfam	phylop	dra_20170914	GRCh38_clinvar_20201226	GRCh38_cosmic_92	GRCh38_dbsnp_154	GRCh38_dgv_20200225	GRCh38_drugbank_20201029	GRCh38_esp6500_20151203	GRCh38_go_20201118	GRCh38_namedVariants_20151113	GRCh38_omim_20201202	GRCh38_pfam_33	GRCh38_phylop_20151118	GRCh38_refgene_201	MyVariantDefaultDb_GRCh38
chr1:11790946	SNV	G	1	C/C	PASS	4.415704473532941e-209	2083.55		268	G=25,C=243	G=0.0933,C=0.9067	90.67	9.329999999999998	homozygous	1	0.246	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1753-48C>G				C	GMAF=0.2298:AMAF=0.1543:EMAF=0.2685					rs576853093:rs1332110504:rs3818762:rs1491370932		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-2.26														
chr1:11791061	SNV	A	1	G/G	PASS	1.9098532585662642e-277	2767.19		280	A=1,G=279	A=0.0036,G=0.9964	99.64	0.35999999999999943	homozygous	1	0.098	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1752+146T>C				G						rs7518348		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.08														
chr1:11792243	SNV	C	1	T/T	PASS	0.0	3967.36		400	C=1,T=399	C=0.0025,T=0.9975	99.75	0.25	homozygous	1	0.251	2		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1632+35G>A				T	GMAF=0.2229:AMAF=0.1491:EMAF=0.2607					rs1476413		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-1.12														
chr1:11794400	SNV	G	1	A/A	PASS	0.0	3989.47		399	G=0,A=399	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.097	1		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	TTT	8	p.Phe435=	c.1305C>T				A	GMAF=0.1095:AMAF=0.3173:EMAF=0.003			Benign		rs756018487:rs4846051		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.65														
chr1:11794419	SNV	T	1	T/G	PASS	7.276122463355338e-98	971.381		400	T=193,G=207	T=0.4825,G=0.5175	51.75	48.25	heterozygous	1	0.249	3		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	missense	GCA	8	p.Glu429Ala	c.1286A>C	0.06	0.021	107.0	G	GMAF=0.2596:AMAF=0.155:EMAF=0.3131	0.96		Conflicting interpretations of pathogenicity, other	3735923.0	rs1801131		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		3.76														
chr1:11800401	SNV	C	1	C/T	PASS	1.8522516912529948e-69	687.323		323	C=166,T=157	C=0.5139,T=0.4861	48.61	51.39	heterozygous	1	0.114	4		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.476-79G>A				T						rs1553187148:rs1553187151:rs2066471		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.24														
chr1:23808231	SNV	T	1	C/C	PASS	0.0	4002.41		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.113	1		HMGCL	NM_000191.3	HMGCL:exonic:NM_000191.3	synonymous	CTG	7	p.Leu218=	c.654A>G				C	GMAF=0.0737:AMAF=0.039:EMAF=0.0915			Benign		rs719400		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	1.23														
chr1:23817442	SNV	A	1	G/G	PASS	0.0	3875.62		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.112	1		HMGCL	NM_000191.3	HMGCL:intronic:NM_000191.3	unknown			p.?	c.252+34T>C				G	GMAF=0.0735:AMAF=0.039:EMAF=0.0912			Benign		rs2076344		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	-1.17														
chr1:45508256	SNV	G	1	G/A	PASS	1.2879529554200043e-69	688.901		399	G=223,A=176	G=0.5589,A=0.4411	44.11	55.89	heterozygous	1	0.475	1		MMACHC	NM_015506.3	MMACHC:exonic:NM_015506.3	synonymous	GTA	3	p.Val107=	c.321G>A				A	GMAF=0.4162:AMAF=0.3723:EMAF=0.437	0.12		Benign	6288212.0	rs2275276		(dui:NBS9;dis:Organic Acid Condition;g:MMACHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMACHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMACHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMACHC)(dui:NBS2;dis:Core Conditions;g:MMACHC)(dui:NBS57;dis:Homocystinuria;g:MMACHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMACHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMACHC)(dui:D008659;dis:Metabolic Diseases;g:MMACHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMACHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMACHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMACHC)(dui:D009748;dis:Nutrition Disorders;g:MMACHC)(dui:D044342;dis:Malnutrition;g:MMACHC)(dui:D003677;dis:Deficiency Diseases;g:MMACHC)(dui:D020138;dis:Hyperhomocysteinemia;g:MMACHC)(dui:D001361;dis:Avitaminosis;g:MMACHC)(dui:D014804;dis:Vitamin B Deficiency;g:MMACHC)(dui:D009422;dis:Nervous System Diseases;g:MMACHC)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MMACHC)(dui:D002493;dis:Central Nervous System Diseases;g:MMACHC)(dui:D003240;dis:Connective Tissue Diseases;g:MMACHC)(dui:D001927;dis:Brain Diseases;g:MMACHC)(dui:D001928;dis:Brain Diseases, Metabolic;g:MMACHC)(dui:D006712;dis:Homocystinuria;g:MMACHC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MMACHC)(dui:D014806;dis:Vitamin B 12 Deficiency;g:MMACHC)(dui:D005128;dis:Eye Diseases;g:MMACHC)(dui:D012164;dis:Retinal Diseases;g:MMACHC)(dui:D012162;dis:Retinal Degeneration;g:MMACHC)(dui:D008268;dis:Macular Degeneration;g:MMACHC)	Hydroxocobalamin:Cyanocobalamin	GO:0071949:GO:0042803:GO:0032451:GO:0009235:GO:0005515:GO:0043295:GO:0005737:GO:0016491:GO:0006749:GO:0031419:GO:0005829:GO:0055114:GO:0016740:GO:0070988:GO:0033787	609831	PF16690	-0.88														
chr1:53210776	SNV	G	1	G/A	PASS	6.9023980384026245e-105	1041.61		400	G=186,A=214	G=0.465,A=0.535	53.50	46.5	heterozygous	1	0.413	1		CPT2	NM_000098.3	CPT2:exonic:NM_000098.3	missense	ATC	4	p.Val368Ile	c.1102G>A	1.0	0.011	29.0	A	GMAF=0.4564:AMAF=0.2901:EMAF=0.4584	0.11		Benign,risk factor	3751293.0	rs1799821		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT2)(dui:NBS3;dis:Secondary Conditions;g:CPT2)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT2)(dui:NBS28;dis:Carnitine palmitoyltransferase II deficiency;g:CPT2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT2)(dui:D008659;dis:Metabolic Diseases;g:CPT2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT2)(dui:D009422;dis:Nervous System Diseases;g:CPT2)(dui:D009140;dis:Musculoskeletal Diseases;g:CPT2)(dui:D009135;dis:Muscular Diseases;g:CPT2)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT2)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT2)(dui:D028361;dis:Mitochondrial Diseases;g:CPT2)(dui:D009468;dis:Neuromuscular Diseases;g:CPT2)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT2)(dui:D004066;dis:Digestive System Diseases;g:CPT2)(dui:D008107;dis:Liver Diseases;g:CPT2)(dui:D007003;dis:Hypoglycemia;g:CPT2)(dui:D007232;dis:Infant, Newborn, Diseases;g:CPT2)(dui:D002493;dis:Central Nervous System Diseases;g:CPT2)(dui:D001927;dis:Brain Diseases;g:CPT2)(dui:D001928;dis:Brain Diseases, Metabolic;g:CPT2)	Perhexiline:Levocarnitine	GO:0016746:GO:0004095:GO:0005730:GO:0006853:GO:0005743:GO:0009437:GO:0005654:GO:0001676:GO:0006635:GO:0005515:GO:0005739:GO:0019216:GO:0120162	600650	PF00755	-0.05														
chr1:75728544	INDEL	GT	1	G/G	PASS	5.5718574893190525e-266	2652.54		399	GT=0,G=399	GT=0.0,G=1.0	100.00	0.0	homozygous	1	0.0	4		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+57delT				G				Benign		rs1454388372:rs75993895:rs1173791164:rs796117827		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.2,0.0														
chr1:75728621	SNV	A	1	G/G	PASS	0.0	3893.28		400	A=3,G=397	A=0.0075,G=0.9925	99.25	0.75	homozygous	1	0.104	2		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+133A>G				G						rs1146572		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-0.18														
chr1:100206504	SNV	T	1	C/C	PASS	0.0	3924.32		400	T=2,C=398	T=0.005,C=0.995	99.50	0.5	homozygous	1	0.108	1		DBT	NM_001918.5	DBT:exonic:NM_001918.5	missense	GGT	9	p.Ser384Gly	c.1150A>G	1.0	0.0	56.0	C	GMAF=0.1408:AMAF=0.2251:EMAF=0.0976			Benign		rs12021720		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	1.94														
chr1:115033402	SNV	A	1	A/G	PASS	1.4608310795053982e-84	838.354		400	A=207,G=193	A=0.5175,G=0.4825	48.25	51.75	heterozygous	1	0.016	1		TSHB	NM_000549.5	TSHB:exonic:NM_000549.5	missense	GCA	2	p.Thr14Ala	c.40A>G	0.32	0.0	58.0	G	GMAF=0.0248:AMAF=0.0057:EMAF=0.0345			Benign		rs10776792		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TSHB)(dui:NBS2;dis:Core Conditions;g:TSHB)(dui:NBS12;dis:Endocrine Disorder;g:TSHB)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TSHB)(dui:D004700;dis:Endocrine System Diseases;g:TSHB)(dui:D013959;dis:Thyroid Diseases;g:TSHB)(dui:D007037;dis:Hypothyroidism;g:TSHB)(dui:D009140;dis:Musculoskeletal Diseases;g:TSHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TSHB)(dui:D001847;dis:Bone Diseases;g:TSHB)(dui:D001849;dis:Bone Diseases, Endocrine;g:TSHB)(dui:D004392;dis:Dwarfism;g:TSHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:TSHB)(dui:D001848;dis:Bone Diseases, Developmental;g:TSHB)(dui:D003409;dis:Congenital Hypothyroidism;g:TSHB)(dui:D009422;dis:Nervous System Diseases;g:TSHB)(dui:D001523;dis:Mental Disorders;g:TSHB)(dui:D000068105;dis:Bipolar and Related Disorders;g:TSHB)(dui:D009461;dis:Neurologic Manifestations;g:TSHB)(dui:D001714;dis:Bipolar Disorder;g:TSHB)(dui:D019954;dis:Neurobehavioral Manifestations;g:TSHB)(dui:D003244;dis:Consciousness Disorders;g:TSHB)(dui:D014474;dis:Unconsciousness;g:TSHB)(dui:D003128;dis:Coma;g:TSHB)		GO:0005615:GO:0043627:GO:0007186:GO:0005737:GO:0051592:GO:0007267:GO:0009653:GO:0016486:GO:0033189:GO:0005576:GO:0005179:GO:0009755	188540		0.21														
chr2:1414420	SNV	C	1	G/G	PASS	0.0	4003.22		400	C=0,G=400	C=0.0,G=1.0	100.00	0.0	homozygous	1	0.312	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	CTG	2	p.Leu4=	c.12C>G				G	GMAF=0.3553:AMAF=0.2905:EMAF=0.3885	0.01		Benign	1399678.0	rs9678281		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-3.72														
chr2:1423015	SNV	G	1	G/A	PASS	2.9668801300209345e-89	885.277		400	G=202,A=198	G=0.505,A=0.495	49.50	50.5	heterozygous	1	0.231	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.95-30G>A				A	GMAF=0.2137:AMAF=0.1841:EMAF=0.229					rs2276701		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.15														
chr2:1433391	SNV	A	1	A/C	PASS	1.9888407051736195e-76	757.014		400	A=216,C=184	A=0.54,C=0.46	46.00	54.0	heterozygous	1	0.399	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.180-47A>C				C	GMAF=0.3166:AMAF=0.4721:EMAF=0.237					rs1473936		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.5														
chr2:1433638	SNV	C	1	C/T	PASS	5.640271374318951e-96	952.487		400	C=195,T=205	C=0.4875,T=0.5125	51.25	48.75	heterozygous	1	0.437	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.349+31C>T				T	GMAF=0.4955:AMAF=0.2935:EMAF=0.4009					rs4927578		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.12														
chr2:1436306	SNV	C	1	C/A	PASS	3.9030130196420944e-57	564.086		294	C=158,A=136	C=0.5374,A=0.4626	46.26	53.74	heterozygous	1	0.009	3		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	CAT	5	p.Pro135His	c.404C>A	0.03	0.999	77.0	A	GMAF=4.0E-4:AMAF=0.0:EMAF=6.0E-4			Benign/Likely benign		rs61758083		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	2.39														
chr2:1456034	SNV	A	1	G/G	PASS	0.0	3468.19		348	A=0,G=348	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.065	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.613-42A>G				G	GMAF=0.0716:AMAF=0.104:EMAF=0.055					rs4927610:rs1036271161		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.86														
chr2:1456232	SNV	G	1	G/T	PASS	7.886784967745048e-82	811.031		400	G=210,T=190	G=0.525,T=0.475	47.50	52.5	heterozygous	1	0.365	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCT	7	p.Ala257Ser	c.769G>T	0.13	0.056	99.0	T	GMAF=0.3813:AMAF=0.3761:EMAF=0.384	0.1		Benign	7302182.0	rs4927611		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.75														
chr2:1456368	SNV	A	1	A/G	PASS	3.879716572936962e-54	534.112		309	A=173,G=136	A=0.5599,G=0.4401	44.01	55.99	heterozygous	1	0.363	3		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.819+86A>G				G	GMAF=0.3765:AMAF=0.3656:EMAF=0.3812					rs4927612		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.09														
chr2:1477383	SNV	G	1	G/T	PASS	1.422983944579351e-57	568.468		289	G=154,T=135	G=0.5329,T=0.4671	46.71	53.29	heterozygous	1	0.408	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCG	8	p.Ala373Ser	c.1117G>T	1.0	0.005	99.0	T	GMAF=0.4069:AMAF=0.3165:EMAF=0.4479	0.03		Benign	3749597.0	rs2280132		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.12														
chr2:1477459	SNV	G	1	G/C	PASS	3.98933034060082e-83	823.991		399	G=208,C=191	G=0.5213,C=0.4787	47.87	52.13	heterozygous	1	0.29	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	ACC	8	p.Ser398Thr	c.1193G>C	0.05	0.999	58.0	C	GMAF=0.2184:AMAF=0.1362:EMAF=0.2602	0.89		Benign	1579950.0	rs2175977		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	1.05														
chr2:1484896	SNV	T	1	T/C	PASS	1.7766423082036193e-56	557.504		273	T=143,C=130	T=0.5238,C=0.4762	47.62	52.38	heterozygous	1	0.403	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+42T>C				C	GMAF=0.4494:AMAF=0.3093:EMAF=0.4789					rs6715129		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.34														
chr2:1484911	SNV	T	1	T/A	PASS	0.00046385260506228863	33.3362		270	T=224,A=46	T=0.8296,A=0.1704	17.04	82.96000000000001	heterozygous	1		7		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+57T>A				A						rs1227929517		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.3														
chr2:1494031	SNV	C	1	C/T	PASS	5.556483128371233e-96	952.552		400	C=195,T=205	C=0.4875,T=0.5125	51.25	48.75	heterozygous	1	0.359	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	GAT	11	p.Asp666=	c.1998C>T				T	GMAF=0.3505:AMAF=0.3221:EMAF=0.3651	0.01		Benign	3757660.0	rs780537993:rs1126797		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-5.14														
chr2:1495956	SNV	C	1	C/T	PASS	3.684681891478696e-97	964.336		387	C=184,T=203	C=0.4755,T=0.5245	52.45	47.55	heterozygous	1	0.273	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.2007-33C>T				T	GMAF=0.2825:AMAF=0.2245:EMAF=0.3123					rs2276704		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.1														
chr2:1496127	SNV	C	1	C/T	PASS	1.9842664984846554e-54	537.024		229	C=113,T=116	C=0.4934,T=0.5066	50.65	49.35	heterozygous	1	0.439	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	CCT	12	p.Pro715=	c.2145C>T				T	GMAF=0.413:AMAF=0.4414:EMAF=0.3985	0.04		Benign	1685440.0	rs732608		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-2.72														
chr2:1496155	SNV	A	1	A/C	PASS	1.0190605747492564e-56	559.918		223	A=106,C=117	A=0.4753,C=0.5247	52.47	47.53	heterozygous	1	0.498	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	CCT	12	p.Thr725Pro	c.2173A>C	1.0	0.0	38.0	C	GMAF=0.4703:AMAF=0.3926:EMAF=0.4001	0.03		Benign	3812428.0	rs732609		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	2.92														
chr2:1516904	SNV	T	1	T/C	PASS	4.8977881936844366e-79	783.1		400	T=213,C=187	T=0.5325,C=0.4675	46.75	53.25	heterozygous	1	0.336	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	GCG	15	p.Val847Ala	c.2540T>C	1.0	0.0	64.0	C	GMAF=0.3867:AMAF=0.2288:EMAF=0.4677	0.0		Benign	148793.0	rs1126799		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.63														
chr2:1542555	SNV	C	1	C/G	PASS	2.5392180698867453e-77	765.953		400	C=215,G=185	C=0.5375,G=0.4625	46.25	53.75	heterozygous	1	0.353	2		TPO	NM_000547.5	TPO:utr_3:NM_000547.5	unknown		17	p.?	c.*81C>G				G	GMAF=0.3815:AMAF=0.2384:EMAF=0.4437	0.0		Benign	4001255.0	rs1042589		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.2														
chr2:1542589	SNV	G	1	G/T	PASS	6.576578373554172e-103	1021.82		400	G=188,T=212	G=0.47,T=0.53	53.00	47.0	heterozygous	1	0.095	3		TPO	NM_000547.5	TPO:utr_3:NM_000547.5	unknown		17	p.?	c.*115G>T				T	GMAF=0.0727:AMAF=0.0195:EMAF=0.0959	0.01		Benign	5653833.0	rs28915689:rs1353412577:rs1558451361		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.06														
chr2:149571002	SNV	C	1	T/T	PASS	2.8313919957993677e-130	1295.48		131	C=0,T=131	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.378	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.696+83G>A				T						rs4500908		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.28														
chr2:149575863	SNV	C	1	G/G	PASS	0.0	3726.32		381	C=2,G=379	C=0.0052,G=0.9948	99.48	0.519999999999996	homozygous	1	0.378	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-22G>C				G	GMAF=0.3774:AMAF=0.3115:EMAF=0.2178			Likely benign		rs12232959		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-2.14														
chr2:149575955	SNV	G	1	T/T	PASS	0.0	3580.89		358	G=0,T=358	G=0.0,T=1.0	100.00	0.0	homozygous	1	0.369	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-114C>A				T						rs10932467		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.8														
chr2:149576462	SNV	C	1	T/T	PASS	0.0	3927.11		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.24	1		MMADHC	NM_015702.3	MMADHC:exonic:NM_015702.3	synonymous	CAA	5	p.Gln151=	c.453G>A				T	GMAF=0.2261:AMAF=0.4839:EMAF=0.094	0.38		Benign	7128893.0	rs11545261		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.09														
chr2:149579375	INDEL	C	2	CAA/CAA	PASS	2.506109253031955e-240	2396.01		347	C=0,CAA=347	C=0.0,CAA=1.0	100.00	0.0	homozygous	1	0.352	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.372+55_372+56insTT				CAA						rs36108609:rs1573878596		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.05														
chr2:149587175	SNV	C	1	G/G	PASS	0.0	3713.62		376	C=1,G=375	C=0.0027,G=0.9973	99.73	0.269999999999996	homozygous	1	0.311	1		MMADHC|MMADHC-DT	NM_015702.3|NR_110240.1	MMADHC:intronic:NM_015702.3|MMADHC-DT:upstream:NR_110240.1	unknown|	|	|	p.?|	c.-52-26G>C|	|	|	|	G|	GMAF=0.2632:AMAF=0.3497:EMAF=0.0949					rs4667420		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.12														
chr3:15645269	SNV	T	1	T/C	PASS	1.6668633588877688e-85	847.781		400	T=206,C=194	T=0.515,C=0.485	48.50	51.5	heterozygous	1	0.164	1		BTD	NM_001281724.3	BTD:exonic:NM_001281724.3	synonymous	TGC	6	p.Cys451=	c.1353T>C				C	GMAF=0.0826:AMAF=0.0701:EMAF=0.089	0.59		Benign	4002499.0	rs3817641		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BTD)(dui:NBS2;dis:Core Conditions;g:BTD)(dui:NBS14;dis:Other Disorder;g:BTD)(dui:NBS70;dis:Biotinidase Deficiency;g:BTD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BTD)(dui:D030342;dis:Genetic Diseases, Inborn;g:BTD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BTD)(dui:D008659;dis:Metabolic Diseases;g:BTD)(dui:D008661;dis:Metabolism, Inborn Errors;g:BTD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:BTD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BTD)(dui:D009100;dis:Multiple Carboxylase Deficiency;g:BTD)(dui:D028921;dis:Biotinidase Deficiency;g:BTD)(dui:D001523;dis:Mental Disorders;g:BTD)(dui:D004066;dis:Digestive System Diseases;g:BTD)(dui:D008107;dis:Liver Diseases;g:BTD)(dui:D065886;dis:Neurodevelopmental Disorders;g:BTD)(dui:D002659;dis:Child Development Disorders, Pervasive;g:BTD)(dui:D056486;dis:Drug-Induced Liver Injury;g:BTD)(dui:D001321;dis:Autistic Disorder;g:BTD)		GO:0047708:GO:0005615:GO:0006768:GO:0007417:GO:0070062:GO:0005759:GO:0005576	609019:608306	PF00795	-0.2														
chr3:49419325	SNV	C	1	C/T	PASS	3.1397856482728466e-58	575.031		254	C=127,T=127	C=0.5,T=0.5	50.00	50.0	heterozygous	1	0.007	2		AMT	NR_028435.2	AMT:exonic_nc:NR_028435.2			6							GMAF=0.0065:AMAF=0.0016:EMAF=0.0091	0.64		Conflicting interpretations of pathogenicity	7355386.0	rs116192290		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine		238310		2.57														
chr3:49421681	SNV	A	1	C/C	PASS	8.356030182311876e-259	2580.78		267	A=2,C=265	A=0.0075,C=0.9925	99.25	0.75	homozygous	1	0.417	3		AMT|NICN1	NR_028435.2|NM_032316.3	AMT:intronic_nc:NR_028435.2|NICN1:downstream:NM_032316.3	|unknown	|	|	|p.?	|c.*3152T>G	|	|	|	|C						rs4855873		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine	GO:0005515:GO:0005654:GO:0005874	238310:611516		1.08														
chr3:183017394	SNV	C	1	C/A	PASS	1.2621181145707582e-74	738.989		295	C=140,A=155	C=0.4746,A=0.5254	52.54	47.46	heterozygous	1	0.047	1		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1978-57G>T				A	GMAF=0.0675:AMAF=0.065:EMAF=0.0685					rs6786878		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	-0.36														
chr3:183037421	SNV	T	1	T/G	PASS	1.501412405754153e-94	938.235		400	T=196,G=204	T=0.49,G=0.51	51.00	49.0	heterozygous	1	0.465	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	missense	CCC	13	p.His464Pro	c.1391A>C	0.01	0.0	77.0	G	GMAF=0.4152:AMAF=0.2876:EMAF=0.2629	0.92		Benign	4002526.0	rs2270968		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	1.12														
chr3:183072461	SNV	G	1	G/A	PASS	1.4275785044217623e-68	678.454		400	G=225,A=175	G=0.5625,A=0.4375	43.75	56.25	heterozygous	1	0.084	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	synonymous	CTT	5	p.Leu132=	c.396C>T				A	GMAF=0.1147:AMAF=0.2034:EMAF=0.0692			Benign		rs7622479		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	0.89														
chr4:158680524	SNV	C	1	T/T	PASS	0.0	3969.57		400	C=1,T=399	C=0.0025,T=0.9975	99.75	0.25	homozygous	1	0.327	1		ETFDH	NM_004453.4	ETFDH:exonic:NM_004453.4	missense	ATA	2	p.Thr31Ile	c.92C>T	0.1	0.0	89.0	T	GMAF=0.3434:AMAF=0.2596:EMAF=0.14	0.84		Benign	4158888.0	rs11559290		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFDH)(dui:NBS3;dis:Secondary Conditions;g:ETFDH)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFDH)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFDH)(dui:D008659;dis:Metabolic Diseases;g:ETFDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFDH)(dui:D028361;dis:Mitochondrial Diseases;g:ETFDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFDH)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFDH)(dui:D009748;dis:Nutrition Disorders;g:ETFDH)(dui:D044343;dis:Overnutrition;g:ETFDH)(dui:D009765;dis:Obesity;g:ETFDH)	Metformin:2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	GO:0009055:GO:0022904:GO:0043783:GO:0004174:GO:0022900:GO:0048039:GO:0006979:GO:0031305:GO:0033539:GO:0005515:GO:0031966:GO:0048038:GO:0005759:GO:0016491:GO:0046872:GO:0050660:GO:0051539	231675	PF01946:PF13450:PF05187:PF00890	1.1														
chr4:158698883	SNV	A	1	A/C	PASS	1.548460031761826e-55	548.101		262	A=136,C=126	A=0.5191,C=0.4809	48.09	51.91	heterozygous	1	0.295	4		ETFDH	NM_004453.4	ETFDH:intronic:NM_004453.4	unknown			p.?	c.973-104A>C				C						rs7679753		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFDH)(dui:NBS3;dis:Secondary Conditions;g:ETFDH)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFDH)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFDH)(dui:D008659;dis:Metabolic Diseases;g:ETFDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFDH)(dui:D028361;dis:Mitochondrial Diseases;g:ETFDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFDH)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFDH)(dui:D009748;dis:Nutrition Disorders;g:ETFDH)(dui:D044343;dis:Overnutrition;g:ETFDH)(dui:D009765;dis:Obesity;g:ETFDH)	Metformin:2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	GO:0009055:GO:0022904:GO:0043783:GO:0004174:GO:0022900:GO:0048039:GO:0006979:GO:0031305:GO:0033539:GO:0005515:GO:0031966:GO:0048038:GO:0005759:GO:0016491:GO:0046872:GO:0050660:GO:0051539	231675	PF01946:PF13450:PF05187:PF00890	-3.15														
chr4:158708662	SNV	A	1	A/C	PASS	9.354056741475598e-105	1040.29		390	A=179,C=211	A=0.459,C=0.541	54.10	45.9	heterozygous	1	0.181	1		ETFDH|PPID	NM_004453.4|NM_005038.3	ETFDH:utr_3:NM_004453.4|PPID:downstream:NM_005038.3	unknown|unknown	|	13|	p.?|p.?	c.*135A>C|c.*1074T>G	|	|	|	C|C				Benign		rs939962290:rs17843966		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFDH)(dui:NBS3;dis:Secondary Conditions;g:ETFDH)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFDH)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFDH)(dui:D008659;dis:Metabolic Diseases;g:ETFDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFDH)(dui:D028361;dis:Mitochondrial Diseases;g:ETFDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFDH)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFDH)(dui:D009748;dis:Nutrition Disorders;g:ETFDH)(dui:D044343;dis:Overnutrition;g:ETFDH)(dui:D009765;dis:Obesity;g:ETFDH)	Metformin:2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	GO:0009055:GO:0022904:GO:0015031:GO:0061077:GO:0043783:GO:0022900:GO:0048039:GO:0000413:GO:0005730:GO:0005654:GO:0000122:GO:0006979:GO:0033539:GO:0071492:GO:0016491:GO:0006915:GO:0005829:GO:0034389:GO:0050714:GO:0045070:GO:0030544:GO:0016018:GO:0031072:GO:0065003:GO:0004174:GO:0008134:GO:0006457:GO:0005634:GO:0031305:GO:0003755:GO:0005515:GO:0031966:GO:0048038:GO:0019076:GO:0005759:GO:0046872:GO:0050660:GO:0005737:GO:0043065:GO:0051879:GO:0051539:GO:0030331	231675:601753	PF01946:PF13450:PF05187:PF00890	0.52														
chr5:71626789	SNV	G	1	A/A	PASS	0.0	3702.92		372	G=0,A=372	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.738+36G>A				A	GMAF=0.2032:AMAF=0.2797:EMAF=0.164			Benign		rs12516456		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-0.73														
chr5:71632256	SNV	C	1	T/T	PASS	0.0	3394.66		341	C=0,T=341	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.39	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.803+71C>T				T						rs277981		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.98														
chr5:71649248	SNV	A	1	G/G	PASS	0.0	3946.72		399	A=1,G=398	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.149	1		MCCC2	NM_022132.5	MCCC2:exonic:NM_022132.5	synonymous	GCG	14	p.Ala456=	c.1368A>G				G	GMAF=0.1868:AMAF=0.2935:EMAF=0.1321	0.07		Benign	4407210.0	rs10064079		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.2														
chr5:71652827	SNV	G	1	A/A	PASS	0.0	4003.3		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.1574+73G>A				A						rs2242372		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	0.28														
chr6:32038540	SNV	C	1	T/T	PASS	3.251621601204801e-47	464.879		49	C=1,T=48	C=0.0204,T=0.9796	97.96	2.0400000000000063	homozygous	1		2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	TTG	1	p.Leu40=	c.118C>T				T		0.61		Benign	4160891.0	rs6468		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.09														
chr6:32038560	SNV	C	1	C/A	PASS	8.328945110456596e-09	80.7941		44	C=25,A=19	C=0.5682,A=0.4318	43.18	56.82	heterozygous	1		4		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CCA	1	p.Pro46=	c.138C>A				A		0.05		Benign	4160892.0	rs6464		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.44														
chr6:32038820	SNV	C	1	C/T	PASS	5.7597018125467215e-25	242.396		95	C=45,T=50	C=0.4737,T=0.5263	52.63	47.37	heterozygous	1	0.288	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+9C>T				T				Benign		rs6462		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.82														
chr6:32039027	SNV	C	1	A/A	PASS	6.776415076106577e-137	1361.69		139	C=1,A=138	C=0.0072,A=0.9928	99.28	0.7199999999999989	homozygous	1	0.176	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-67C>A				A						rs6451:rs1562756023		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.11														
chr6:32039081	SNV	C	1	C/A	PASS	1.1748975549395496e-103	1029.3		142	C=17,A=125	C=0.1197,A=0.8803	88.03	11.969999999999999	heterozygous	1	0.348	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-13C>A				A	GMAF=0.3707:AMAF=0.3445:EMAF=0.384			Conflicting interpretations of pathogenicity		rs6467:rs1267808195		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.23														
chr6:32039286	SNV	C	1	T/T	PASS	1.5885467485978587e-270	2697.99		273	C=0,T=273	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.313	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.447+38C>T				T	GMAF=0.2787:AMAF=0.295:EMAF=0.2704			Benign		rs6466		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.86														
chr6:32039847	MNV	AC	2	AC/GT	PASS	7.478250350455694e-69	681.262		309	AC=156,GT=153	AC=0.5049,GT=0.4951	49.51	50.49	0	1	0.173:0.174	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.738+12_738+13delinsGT				GT	GMAF=0.034:AMAF=0.0545:EMAF=0.0235			Uncertain significance		rs193922547:rs6458:rs6459:rs1554305325:rs71552100		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.57,-3.0														
chr6:32040013	SNV	C	1	C/G	PASS	3.0394849687700947e-35	345.172		236	C=140,G=96	C=0.5932,G=0.4068	40.68	59.32	heterozygous	1	0.214	1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CTG	7	p.Leu249=	c.747C>G				G		0.01		Benign	4003960.0	rs6477		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.02														
chr6:32040072	SNV	G	1	G/C	PASS	1.6050922580968928e-33	327.945		246	G=150,C=96	G=0.6098,C=0.3902	39.02	60.98	heterozygous	1	0.196	1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	missense	ACC	7	p.Ser269Thr	c.806G>C	0.18	0.022	58.0	C	GMAF=0.1412:AMAF=0.2191:EMAF=0.0978	0.05		Benign	7226575.0	rs760900241:rs6472		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.98														
chr6:39927671	SNV	T	1	C/C	PASS	5.046612975635318e-199	1982.97		203	T=1,C=202	T=0.0049,C=0.9951	99.51	0.4899999999999949	homozygous	1	0.377	2		MOCS1	NM_001358530.2	MOCS1:intronic:NM_001358530.2	unknown			p.?	c.124-216A>G				C				Benign		rs3008822		(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MOCS1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MOCS1)(dui:D008659;dis:Metabolic Diseases;g:MOCS1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MOCS1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MOCS1)(dui:D008664;dis:Metal Metabolism, Inborn Errors;g:MOCS1)			603707	PF01967:PF04055:PF06463:PF13353	-0.93														
chr6:49435569	SNV	T	1	C/C	PASS	0.0	3858.58		391	T=1,C=390	T=0.0026,C=0.9974	99.74	0.2600000000000051	homozygous	1	0.451	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	GTA	12	p.Ile671Val	c.2011A>G	1.0	0.0	29.0	C	GMAF=0.393:AMAF=0.4122:EMAF=0.3833	0.25		Benign	4004063.0	rs8589		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	3.9														
chr6:49441774	SNV	G	1	C/C	PASS	0.0	3990.43		399	G=0,C=399	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.329	1		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1808+66C>G				C						rs9473555		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.46														
chr6:49444720	SNV	C	1	T/T	PASS	0.0	3402.96		342	C=0,T=342	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.266	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	CAT	9	p.Arg532His	c.1595G>A	0.0	0.225	29.0	T	GMAF=0.3135:AMAF=0.2108:EMAF=0.366	0.03		Benign	5001998.0	rs1141321		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	-0.01														
chr6:49447650	SNV	A	1	A/G	PASS	8.439369461730709e-07	60.7369		95	A=69,G=26	A=0.7263,G=0.2737	27.37	72.63	heterozygous	1		16		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1560+20T>C				G								.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.41														
chr6:49447651	SNV	A	1	A/G	PASS	0.0023358233740013	26.3156		96	A=75,G=21	A=0.7813,G=0.2188	21.88	78.12	heterozygous	1		16		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1560+19T>C				G								.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	-0.71														
chr6:49453535	SNV	T	1	T/A	PASS	1.1486824875460957e-65	649.398		366	T=202,A=164	T=0.5519,A=0.4481	44.81	55.19	heterozygous	1	0.009	1		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1083+50A>T				A						rs192976390:rs1396844853		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.3														
chr6:49457808	SNV	C	1	T/T	PASS	0.0	3927.2		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.449	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	synonymous	AAA	3	p.Lys212=	c.636G>A				T	GMAF=0.3984:AMAF=0.4274:EMAF=0.3836	0.39		Benign	6350580.0	rs2229384		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.67														
chr6:80107031	SNV	T	1	T/C	PASS	5.841172070928217e-63	622.335		248	T=118,C=130	T=0.4758,C=0.5242	52.42	47.58	heterozygous	1	0.388	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.196+142T>C				C						rs35447745		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.0														
chr6:80127522	SNV	A	1	A/G	PASS	1.7984567574769368e-44	437.451		263	A=149,G=114	A=0.5665,G=0.4335	43.35	56.65	heterozygous	1	0.388	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.197-25A>G				G	GMAF=0.323:AMAF=0.1148:EMAF=0.4297			Benign		rs9448893		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.45														
chr6:80167654	SNV	C	1	C/T	PASS	1.3013676301074749e-74	738.856		383	C=205,T=178	C=0.5352,T=0.4648	46.48	53.52	heterozygous	1	0.13	2		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.344-24C>T				T	GMAF=0.0657:AMAF=0.0985:EMAF=0.0488			Benign/Likely benign		rs73479953		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.74														
chr6:80168795	SNV	G	1	G/A	PASS	2.4587252428788657e-05	46.0929		7	G=1,A=6	G=0.1429,A=0.8571	85.71	14.290000000000006	heterozygous	1	0.0	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.478-80G>A				A						rs72908865		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.72														
chr6:80203260	SNV	C	1	C/T	PASS	1.686553025388756e-104	1037.73		370	C=165,T=205	C=0.4459,T=0.5541	55.41	44.59	heterozygous	1	0.13	2		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.951+48C>T				T	GMAF=0.0658:AMAF=0.0987:EMAF=0.049			Benign/Likely benign		rs3749896		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.16														
chr6:80272984	SNV	G	1	G/A	PASS	6.5614526630289485e-102	1011.83		400	G=189,A=211	G=0.4725,A=0.5275	52.75	47.25	heterozygous	1	0.403	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.952-151G>A				A						rs9341811		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.85														
chr7:117536538	INDEL	TGATT	4	T/T	PASS	5.128613839913407e-196	1952.9		200	TGATT=0,T=200	TGATT=0.0,T=1.0	100.00	0.0	homozygous	1		1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.744-9_744-6delGATT				T						rs1584787644:rs397508793:rs387906367:rs1584787639:rs1554380751:rs878854022		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.15,0.0,0.0,-0.48,2.25														
chr7:117548629	INDEL	T	1	T/TG	PASS	3.8370724549228156e-77	764.16		213	T=72,TG=141	T=0.338,TG=0.662	66.20	33.8	heterozygous	1	0.071:0.003	0		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-12_1210-11insG|	|	|	|	TG|			5T	Uncertain significance		rs4148705:rs1584793368:rs1805177:rs765376630:rs1399483116		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.56														
chr7:117548630	INDEL	T	2	T/TGT	PASS	6.4491131986810554e-24	231.905		221	T=141,TGT=80	T=0.638,TGT=0.362	36.20	63.8	heterozygous	1	0.071:0.002	0		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-11_1210-10insGT|	|	|	|	TGT|	GMAF=0.0033:AMAF=0.0011:EMAF=0.0044					rs551227135:rs73715573:rs1584793368:rs1805177:rs765376630:rs1399483116		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.24														
chr7:117559403	SNV	A	1	G/G	PASS	0.0	3982.82		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.337	1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1393-61A>G|	|	|	|	G|				Benign		rs34855237		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.3														
chr7:117559479	SNV	G	1	A/A	PASS	0.0	3935.12		400	G=2,A=398	G=0.005,A=0.995	99.50	0.5	homozygous	1	0.418	2		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:exonic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	missense|	ATG|	11|	p.Val470Met|	c.1408G>A|	1.0|	0.0|	21.0|	A|	GMAF=0.4024:AMAF=0.1496:EMAF=0.4681	0.39	M470V	Benign/Likely benign	3762337.0	rs397508204:rs213950		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		2.57														
chr7:117595001	SNV	T	1	G/G	PASS	0.0	3998.56		400	T=0,G=400	T=0.0,G=1.0	100.00	0.0	homozygous	1	0.479	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	ACG	15	p.Thr854=	c.2562T>G				G	GMAF=0.4028:AMAF=0.3813:EMAF=0.2922	0.13		Benign/Likely benign	4161733.0	rs1584813846:rs1554389814:rs397508396:rs1042077		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.28														
chr7:117606582	SNV	G	1	A/A	PASS	0.0	3313.7		333	G=0,A=333	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.119	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.2909-92G>A				A				Benign		rs35050470		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.23														
chr7:117627457	SNV	C	1	A/A	PASS	4.4e-323	3223.3		324	C=0,A=324	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.144	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.3469-65C>A				A				Benign		rs213989		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.12														
chr7:117667054	SNV	G	1	A/A	PASS	0.0	3998.78		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.186	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	CAA	27	p.Gln1463=	c.4389G>A				A	GMAF=0.2259:AMAF=0.2444:EMAF=0.2164	0.11		Benign/Likely benign	3762339.0	rs1800136:rs1584850283		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.01														
chr8:142874241	SNV	A	1	A/G	PASS	7.045308260712095e-89	881.521		348	A=163,G=185	A=0.4684,G=0.5316	53.16	46.84	heterozygous	1	0.121	1		CYP11B1	NM_000497.4	CYP11B1:utr_3:NM_000497.4	unknown		9	p.?	c.*132T>C				G				Benign		rs5297		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.32														
chr8:142874500	SNV	C	1	C/G	PASS	2.5392180698867456e-80	795.953		319	C=152,G=167	C=0.4765,G=0.5235	52.35	47.65	heterozygous	1	0.114	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1399-14G>C				G	GMAF=0.1352:AMAF=0.234:EMAF=0.0845			Benign		rs5295		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.56														
chr8:142875392	SNV	A	1	C/C	PASS	1.4454397707458216e-270	2698.4		273	A=0,C=273	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.259	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-80T>G				C						rs6395		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.29														
chr8:142875438	SNV	G	1	G/A	PASS	1.4845676750522655e-100	998.284		333	G=142,A=191	G=0.4264,A=0.5736	57.36	42.64	heterozygous	1	0.121	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-126C>T				A						rs61752788		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		0.22														
chr8:142875509	SNV	T	1	C/C	PASS	0.0	3521.08		356	T=0,C=356	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.24	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-197A>G				C						rs6392		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.07														
chr8:142876322	SNV	C	1	C/T	PASS	1.972876955525738e-86	857.049		400	C=205,T=195	C=0.5125,T=0.4875	48.75	51.25	heterozygous	1	0.114	2		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	GCA	5	p.Ala291=	c.873G>A				T	GMAF=0.087:AMAF=0.2088:EMAF=0.0245	0.0		Benign	7249011.0	rs34570566		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.62														
chr8:142876440	SNV	G	1	A/A	PASS	0.0	4003.33		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.315	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.800-45C>T				A	GMAF=0.4197:AMAF=0.3926:EMAF=0.4336					rs7822986		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-1.98														
chr8:142876563	SNV	A	1	A/C	PASS	1.012744748814526e-98	979.945		128	A=13,C=115	A=0.1016,C=0.8984	89.84	10.159999999999997	heterozygous	1	0.382	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.799+119T>G				C						rs10956991		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.19														
chr8:142876926	SNV	G	1	G/A	PASS	2.844461107447873e-60	595.46		296	G=156,A=140	G=0.527,A=0.473	47.30	52.7	heterozygous	1	0.171	3		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.596-41C>T				A				Benign		rs113759408		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.61														
chr8:142877011	SNV	C	1	C/T	PASS	1.9498445997580097e-86	857.1		400	C=205,T=195	C=0.5125,T=0.4875	48.75	51.25	heterozygous	1	0.436	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.595+12G>A				T	GMAF=0.4845:AMAF=0.3736:EMAF=0.4587			Benign		rs6387		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.01														
chr8:142879589	SNV	T	1	T/C	PASS	3.5277678661887354e-72	714.525		290	T=139,C=151	T=0.4793,C=0.5207	52.07	47.93	heterozygous	1	0.416	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	CTG	1	p.Leu75=	c.225A>G				C	GMAF=0.4923:AMAF=0.4424:EMAF=0.4588	0.05		Benign	6338105.0	rs6410		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.64														
chr10:102831425	SNV	G	1	G/T	PASS	3.801018645547623e-79	784.201		399	G=212,T=187	G=0.5313,T=0.4687	46.87	53.13	heterozygous	1	0.142	2		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1243+83C>A				T						rs284849		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.16														
chr10:123041337	SNV	C	1	T/T	PASS	0.0	3882.48		389	C=0,T=389	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.228	1		ACADSB	NM_001609.4	ACADSB:exonic:NM_001609.4	synonymous	CAT	5	p.His213=	c.639C>T				T	GMAF=0.2281:AMAF=0.2156:EMAF=0.2345	0.02		Benign	3997809.0	rs1140591		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		-1.56														
chr11:5226496	SNV	G	1	G/A	PASS	9.390743968513712e-85	840.273		321	G=149,A=172	G=0.4642,A=0.5358	53.58	46.42	heterozygous	1	0.099	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+81C>T				A				Benign		rs7946748		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.45														
chr11:5226503	SNV	A	1	A/C	PASS	1.4076672283622593e-63	628.515		318	A=169,C=149	A=0.5314,C=0.4686	46.86	53.14	heterozygous	1	0.369	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+74T>G				C				Benign		rs7480526		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	0.17														
chr11:5226561	SNV	C	1	C/G	PASS	3.86901131655104e-69	684.124		324	C=167,G=157	C=0.5154,G=0.4846	48.46	51.54	heterozygous	1	0.28	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+16G>C				G	GMAF=0.1491:AMAF=0.1297:EMAF=0.159			Benign/Likely benign		rs10768683		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-3.19														
chr11:5227013	SNV	A	1	A/G	PASS	1.8535316234148146e-109	1087.32		399	A=181,G=218	A=0.4536,G=0.5464	54.64	45.36	heterozygous	1	0.286	1		HBB	NM_000518.5	HBB:exonic:NM_000518.5	synonymous	CAC	1	p.His3=	c.9T>C				G	GMAF=0.1513:AMAF=0.1361:EMAF=0.1591	0.1		Benign	6484194.0	rs713040:rs63750898:rs63750407		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.89														
chr11:66850932	SNV	A	1	A/C	PASS	1.0000000000000001e-104	1040.0		357	A=155,C=202	A=0.4342,C=0.5658	56.58	43.42	heterozygous	1	0.026	2		PC	NM_001040716.2	PC:intronic:NM_001040716.2	unknown			p.?	c.2224-9T>G				C				Benign		rs45560936		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PC)(dui:D008659;dis:Metabolic Diseases;g:PC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PC)(dui:D030342;dis:Genetic Diseases, Inborn;g:PC)(dui:D009422;dis:Nervous System Diseases;g:PC)(dui:D008661;dis:Metabolism, Inborn Errors;g:PC)(dui:D002493;dis:Central Nervous System Diseases;g:PC)(dui:D001927;dis:Brain Diseases;g:PC)(dui:D001928;dis:Brain Diseases, Metabolic;g:PC)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:PC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PC)(dui:D028361;dis:Mitochondrial Diseases;g:PC)(dui:D015324;dis:Pyruvate Carboxylase Deficiency Disease;g:PC)(dui:D015323;dis:Pyruvate Metabolism, Inborn Errors;g:PC)(dui:D009369;dis:Neoplasms;g:PC)(dui:D009370;dis:Neoplasms by Histologic Type;g:PC)(dui:D007154;dis:Immune System Diseases;g:PC)(dui:D004700;dis:Endocrine System Diseases;g:PC)(dui:D044882;dis:Glucose Metabolism Disorders;g:PC)(dui:D004066;dis:Digestive System Diseases;g:PC)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:PC)(dui:D003920;dis:Diabetes Mellitus;g:PC)(dui:D007160;dis:Immunoproliferative Disorders;g:PC)(dui:D008107;dis:Liver Diseases;g:PC)(dui:D008206;dis:Lymphatic Diseases;g:PC)(dui:D008103;dis:Liver Cirrhosis;g:PC)(dui:D008223;dis:Lymphoma;g:PC)(dui:D008232;dis:Lymphoproliferative Disorders;g:PC)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:PC)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:PC)(dui:D016393;dis:Lymphoma, B-Cell;g:PC)(dui:D002051;dis:Burkitt Lymphoma;g:PC)	5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal:Pyruvic acid:Biotin	GO:0006094:GO:0042802:GO:0009374:GO:0044794:GO:0005524:GO:0010629:GO:0019074:GO:0005515:GO:0006768:GO:0044791:GO:0004736:GO:0005737:GO:0005759:GO:0046872:GO:0005739:GO:0006629:GO:0005829:GO:0006090	608786:612283	PF00682:PF07478:PF00364:PF02786:PF02785:PF00289:PF02436	0.91														
chr11:68780792	SNV	C	1	A/A	PASS	0.0	3983.35		398	C=0,A=398	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.107	1		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.1353-47G>T				A	GMAF=0.0881:AMAF=0.1534:EMAF=0.0546					rs750602950:rs3019576		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	-0.99														
chr11:68781872	SNV	A	1	G/G	PASS	0.0	3698.22		399	A=9,G=390	A=0.0226,G=0.9774	97.74	2.260000000000005	homozygous	1	0.107	3		CPT1A	NM_001876.4	CPT1A:exonic:NM_001876.4	synonymous	TTC	11	p.Phe417=	c.1251T>C				G	GMAF=0.088:AMAF=0.153:EMAF=0.0547			Benign		rs755361411:rs2228502		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.3														
chr11:68799181	MNV	AAA	3	GCT/GCT	PASS	4.854896771016029e-07	63.1382		7	AAA=0,GCT=7	AAA=0.0,GCT=1.0	100.00	0.0	0	1	0.436:0.281:0.157	5		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.693+35_693+37delinsAGC				GCT						rs61887062:rs373853770:rs61887064:rs200844352:rs67266031:rs1302471537:rs61887063:rs1555230749:rs371123694:rs753779449:rs776600347		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.35,0.91,0.14														
chr11:108121585	SNV	C	1	G/G	PASS	0.0	3934.53		400	C=2,G=398	C=0.005,G=0.995	99.50	0.5	homozygous	1	0.095	2		ACAT1	NM_000019.4	ACAT1:utr_5:NM_000019.4	unknown		1	p.?	c.-22C>G				G	GMAF=0.1296:AMAF=0.0849:EMAF=0.1527			Benign		rs3741054		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-1.57														
chr11:108138933	SNV	C	1	A/A	PASS	0.0	4002.56		400	C=0,A=400	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.127	2		ACAT1	NM_000019.4	ACAT1:exonic:NM_000019.4	synonymous	TCA	6	p.Ser157=	c.471C>A				A	GMAF=0.1818:AMAF=0.1958:EMAF=0.1746	0.83		Benign	1350699.0	rs1591367422:rs35188041		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	0.17														
chr11:108141783	INDEL	A	4	AAAGT/AAAGT	PASS	1.520547529732553e-307	3068.18		330	A=6,AAAGT=324	A=0.0182,AAAGT=0.9818	98.18	1.8199999999999932	homozygous	1	0.007:0.003	5		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.826+83_826+84insAAGT				AAAGT				Benign		rs10682490:rs34420529		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	1.38														
chr12:56004670	SNV	G	1	C/C	PASS	0.0	3933.97		400	G=2,C=398	G=0.005,C=0.995	99.50	0.5	homozygous	1	0.237	2		SUOX	NM_001032387.2	SUOX:exonic:NM_001032387.2	synonymous	TCC	4	p.Ser427=	c.1281G>C				C	GMAF=0.2642:AMAF=0.3768:EMAF=0.0802			Benign		rs1565799723:rs773115		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:SUOX)(dui:D008659;dis:Metabolic Diseases;g:SUOX)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:SUOX)(dui:D030342;dis:Genetic Diseases, Inborn;g:SUOX)(dui:D008661;dis:Metabolism, Inborn Errors;g:SUOX)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:SUOX)(dui:D007154;dis:Immune System Diseases;g:SUOX)(dui:D004700;dis:Endocrine System Diseases;g:SUOX)(dui:D001327;dis:Autoimmune Diseases;g:SUOX)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:SUOX)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:SUOX)(dui:D009140;dis:Musculoskeletal Diseases;g:SUOX)(dui:D009369;dis:Neoplasms;g:SUOX)(dui:D003240;dis:Connective Tissue Diseases;g:SUOX)(dui:D003560;dis:Cysts;g:SUOX)(dui:D006058;dis:Gonadal Disorders;g:SUOX)(dui:D007592;dis:Joint Diseases;g:SUOX)(dui:D012216;dis:Rheumatic Diseases;g:SUOX)(dui:D052776;dis:Female Urogenital Diseases;g:SUOX)(dui:D001168;dis:Arthritis;g:SUOX)(dui:D001172;dis:Arthritis, Rheumatoid;g:SUOX)(dui:D005831;dis:Genital Diseases, Female;g:SUOX)(dui:D010048;dis:Ovarian Cysts;g:SUOX)(dui:D010049;dis:Ovarian Diseases;g:SUOX)(dui:D000291;dis:Adnexal Diseases;g:SUOX)(dui:D011085;dis:Polycystic Ovary Syndrome;g:SUOX)	{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum	GO:0005758:GO:0005515:GO:0006790:GO:0070221:GO:0005759:GO:0005739:GO:0008482:GO:0030151:GO:0020037:GO:0043546	606887	PF00173:PF00174:PF03404	-1.35														
chr12:102843690	SNV	G	1	G/C	PASS	2.8379190284415753e-105	1045.47		399	G=185,C=214	G=0.4637,C=0.5363	53.63	46.37	heterozygous	1	0.16	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CTG	12	p.Leu385=	c.1155C>G				C	GMAF=0.1728:AMAF=0.1959:EMAF=0.161			Benign		rs772897		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.1														
chr12:102855146	SNV	C	1	C/T	PASS	2.4043628000069348e-107	1066.19		399	C=183,T=216	C=0.4586,T=0.5414	54.14	45.86	heterozygous	1	0.454	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CAA	7	p.Gln232=	c.696G>A				T	GMAF=0.3465:AMAF=0.2317:EMAF=0.4052	0.02		Benign	7233325.0	rs1126758		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-2.59														
chr12:102894571	SNV	A	1	A/T	PASS	9.545528969328564e-79	780.202		306	A=144,T=162	A=0.4706,T=0.5294	52.94	47.06	heterozygous	1	0.126	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.352+164T>A				T						rs78243047		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	0.07														
chr12:102912772	SNV	A	1	A/G	PASS	1.411237148411849e-28	278.504		260	A=168,G=92	A=0.6462,G=0.3538	35.38	64.62	heterozygous	1	0.217	3		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.168+19T>C				G	GMAF=0.2069:AMAF=0.2916:EMAF=0.1635			Benign		rs17842947		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	2.01														
chr12:102917009	SNV	G	1	A/A	PASS	4.666593803143006e-101	1003.31		100	G=0,A=100	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.364	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.60+62C>T				A	GMAF=0.3771:AMAF=0.487:EMAF=0.318			Benign		rs1522296		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.51														
chr12:102917201	SNV	T	1	T/G	PASS	2.327555256554288e-54	536.331		175	T=74,G=101	T=0.4229,G=0.5771	57.71	42.29	heterozygous	1	0.126	1		PAH	NM_001354304.2	PAH:utr_5:NM_001354304.2	unknown		2	p.?	c.-71A>C				G	GMAF=0.1586:AMAF=0.185:EMAF=0.1471			Benign		rs2280615:rs1221435279		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.29														
chr12:109557065	SNV	A	1	A/T	PASS	3.273406948788493e-105	1044.85		399	A=185,T=214	A=0.4637,T=0.5363	53.63	46.37	heterozygous	1	0.487	1		MMAB	NM_052845.4	MMAB:exonic:NM_052845.4	missense	AAG	9	p.Met239Lys	c.716T>A	1.0	0.0	95.0	T	GMAF=0.4037:AMAF=0.2792:EMAF=0.4676	0.12		Benign	3752888.0	rs9593		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAB)(dui:NBS2;dis:Core Conditions;g:MMAB)(dui:NBS9;dis:Organic Acid Condition;g:MMAB)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAB)(dui:D008659;dis:Metabolic Diseases;g:MMAB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAB)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAB)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAB)	Cyanocobalamin	GO:0005524:GO:0005515:GO:0005759:GO:0031419:GO:0008817:GO:0009235	607568	PF01923	-0.02														
chr12:109565014	SNV	A	1	A/G	PASS	3.029005068166248e-90	895.187		400	A=201,G=199	A=0.5025,G=0.4975	49.75	50.25	heterozygous	1	0.482	2		MMAB	NM_052845.4	MMAB:intronic:NM_052845.4	unknown			p.?	c.348+105T>C				G				Benign		rs10850380		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAB)(dui:NBS2;dis:Core Conditions;g:MMAB)(dui:NBS9;dis:Organic Acid Condition;g:MMAB)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAB)(dui:D008659;dis:Metabolic Diseases;g:MMAB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAB)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAB)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAB)	Cyanocobalamin	GO:0005524:GO:0005515:GO:0005759:GO:0031419:GO:0008817:GO:0009235	607568	PF01923	0.41														
chr12:120737096	SNV	T	1	C/C	PASS	0.0	3909.16		397	T=1,C=396	T=0.0025,C=0.9975	99.75	0.25	homozygous	1	0.409	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGC	3	p.Arg107=	c.321T>C				C	GMAF=0.4932:AMAF=0.3756:EMAF=0.4466	0.28		Benign	3765623.0	rs1064795254:rs3914		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.18														
chr12:120738181	SNV	T	1	C/C	PASS	0.0	3956.39		399	T=1,C=398	T=0.0025,C=0.9975	99.75	0.25	homozygous	1	0.406	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.625-99T>C				C						rs555404		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-2.88														
chr12:120738280	SNV	G	1	A/A	PASS	0.0	3851.8		399	G=4,A=395	G=0.01,A=0.99	99.00	1.0	homozygous	1	0.182	3		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	missense	AGC	6	p.Gly209Ser	c.625G>A	0.01	0.664	56.0	A	GMAF=0.1968:AMAF=0.0645:EMAF=0.2647	0.97		Benign/Likely benign	3752964.0	rs1799958		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	9.56														
chr12:120738876	SNV	C	1	T/T	PASS	2.5585858869057373e-280	2795.92		289	C=3,T=286	C=0.0104,T=0.9896	98.96	1.0400000000000063	homozygous	1	0.327	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGT	8	p.Arg330=	c.990C>T				T	GMAF=0.408:AMAF=0.1235:EMAF=0.4462	0.02		Benign	4146720.0	rs796051906:rs1555244280:rs3915		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.49														
chr12:120739469	SNV	G	1	C/C	PASS	4.197589839909983e-270	2693.77		271	G=0,C=271	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.193	2		ACADS	NM_000017.4	ACADS:utr_3:NM_000017.4	unknown		10	p.?	c.*21G>C				C	GMAF=0.1979:AMAF=0.0849:EMAF=0.2557			Benign		rs3916		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.11														
chr13:100089101	SNV	G	1	G/A	PASS	9.338991927414188e-70	690.297		345	G=182,A=163	G=0.5275,A=0.4725	47.25	52.75	heterozygous	1	0.001	4		PCCA-DT|PCCA	NR_132422.1|NR_148031.2	PCCA-DT:upstream:NR_132422.1|PCCA:exonic_nc:NR_148031.2	|	|	|1	|	|	|	|	|	|	GMAF=2.0E-4:AMAF=0.0:EMAF=4.0E-4			Conflicting interpretations of pathogenicity		rs1487281977:rs374941593		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	0.34														
chr13:100157391	SNV	G	1	G/A	PASS	6.760829753919789e-101	1001.7		400	G=190,A=210	G=0.475,A=0.525	52.50	47.5	heterozygous	1	0.12	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.1706:AMAF=0.1707:EMAF=0.1705					rs35055557		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.46														
chr13:100235868	SNV	A	1	A/G	PASS	3.026216535763286e-77	765.191		395	A=211,G=184	A=0.5342,G=0.4658	46.58	53.42	heterozygous	1	0.103	2		PCCA	NR_148031.2	PCCA:exonic_nc:NR_148031.2			8							GMAF=0.1515:AMAF=0.1119:EMAF=0.1719	0.88		Benign	7248047.0	rs538229		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	5.13														
chr13:100235980	SNV	A	1	A/G	PASS	1.3803842646028866e-77	768.6		399	A=214,G=185	A=0.5363,G=0.4637	46.37	53.63	heterozygous	1	0.103	2		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2															rs539158		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	1.6														
chr13:100236000	SNV	C	1	C/G	PASS	6.381165375104247e-99	981.951		400	C=192,G=208	C=0.48,G=0.52	52.00	48.0	heterozygous	1	0.002	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2															rs558268563		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	0.82														
chr13:100268802	SNV	A	1	G/G	PASS	0.0	3713.75		400	A=9,G=391	A=0.0225,G=0.9775	97.75	2.25	homozygous	1	0.084	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.0825:AMAF=0.2419:EMAF=8.0E-4			Benign		rs4306370		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.76														
chr13:100368441	SNV	A	1	G/G	PASS	0.0	3588.45		360	A=0,G=360	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.447	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.3177:AMAF=0.4921:EMAF=0.2284			Benign		rs9518061		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.28														
chr15:40411410	SNV	A	1	G/G	PASS	0.0	3913.4		396	A=1,G=395	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.022	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2													Benign		rs4924466		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.1														
chr15:40412906	SNV	A	1	G/G	PASS	0.0	4003.16		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.317	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs2289330		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.42														
chr15:40416223	SNV	A	1	A/G	PASS	4.7304232439996384e-86	853.251		399	A=204,G=195	A=0.5113,G=0.4887	48.87	51.13	heterozygous	1	0.368	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4227:AMAF=0.4324:EMAF=0.3485			Benign		rs11070270		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.49														
chr15:76226005	INDEL	C	5	CCCTTA/CCCTTA	PASS	2.1627185237269184e-266	2656.65		270	C=0,CCCTTA=270	C=0.0,CCCTTA=1.0	100.00	0.0	homozygous	1	0.031	2		ETFA	NM_000126.4	ETFA:intronic:NM_000126.4	unknown			p.?	c.883-77_883-76insTAAGG				CCCTTA						rs11281932:rs112972949		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFA)(dui:NBS3;dis:Secondary Conditions;g:ETFA)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFA)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFA)(dui:D008659;dis:Metabolic Diseases;g:ETFA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFA)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFA)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFA)(dui:D028361;dis:Mitochondrial Diseases;g:ETFA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFA)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFA)(dui:D009140;dis:Musculoskeletal Diseases;g:ETFA)(dui:D007592;dis:Joint Diseases;g:ETFA)(dui:D012216;dis:Rheumatic Diseases;g:ETFA)(dui:D001168;dis:Arthritis;g:ETFA)(dui:D009369;dis:Neoplasms;g:ETFA)(dui:D009370;dis:Neoplasms by Histologic Type;g:ETFA)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:ETFA)(dui:D004066;dis:Digestive System Diseases;g:ETFA)(dui:D009371;dis:Neoplasms by Site;g:ETFA)(dui:D008107;dis:Liver Diseases;g:ETFA)(dui:D002277;dis:Carcinoma;g:ETFA)(dui:D000230;dis:Adenocarcinoma;g:ETFA)(dui:D004067;dis:Digestive System Neoplasms;g:ETFA)(dui:D008113;dis:Liver Neoplasms;g:ETFA)(dui:D010003;dis:Osteoarthritis;g:ETFA)(dui:D006528;dis:Carcinoma, Hepatocellular;g:ETFA)		GO:0033539:GO:0005515:GO:0005759:GO:0016491:GO:0050660:GO:0009055:GO:0005739:GO:0022904	608053	PF00766:PF01012	0.16														
chr15:80152950	SNV	G	1	C/C	PASS	3.491403154785913e-155	1544.57		164	G=3,C=161	G=0.0183,C=0.9817	98.17	1.8299999999999983	homozygous	1	0.186	5		FAH	NM_000137.4	FAH:upstream:NM_000137.4	unknown			p.?	c.-105G>C				C				Benign		rs112474268		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-2.77														
chr15:80153176	INDEL	TGGAG	4	T/T	PASS	4.4668359215096896e-135	1343.5		204	TGGAG=0,T=204	TGGAG=0.0,T=1.0	100.00	0.0	homozygous	1	0.031	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+42_81+45delGGAG				T						rs777902403:rs57837512:rs767638459:rs762924131:rs558321563:rs756381638:rs752679360:rs1555440100:rs554422109		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.07,3.12,1.98,-0.67,1.26														
chr15:80153209	INDEL	AGTGGA	5	AGTGGA/A	PASS	4.292398159704706e-57	563.673		183	AGTGGA=75,A=108	AGTGGA=0.4098,A=0.5902	59.02	40.98	heterozygous	1	0.0	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+75_81+79delGTGGA				A						rs1567112946:rs534184772:rs1361931262:rs1316986199:rs867498731:rs1341663234		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.35,0.39,0.16,0.21,0.17,-0.94														
chr15:80159733	SNV	T	1	C/C	PASS	1.4598223215980475e-100	998.357		110	T=4,C=106	T=0.0364,C=0.9636	96.36	3.6400000000000006	homozygous	1	0.367	6		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.193-23T>C				C	GMAF=0.3974:AMAF=0.3865:EMAF=0.4029			Benign		rs1370274		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.14														
chr15:80159830	SNV	G	1	C/C	PASS	2.1877616239495696e-158	1576.6		158	G=0,C=158	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.06	1		FAH	NM_000137.4	FAH:exonic:NM_000137.4	synonymous	CTC	3	p.Leu89=	c.267G>C				C	GMAF=0.0822:AMAF=0.0774:EMAF=0.0847	0.74		Benign	3999621.0	rs33929922		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	1.56														
chr15:80159926	SNV	G	1	A/A	PASS	1.570362804333545e-172	1718.04		183	G=2,A=181	G=0.0109,A=0.9891	98.91	1.0900000000000034	homozygous	1	0.36	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.314+49G>A				A	GMAF=0.3919:AMAF=0.3684:EMAF=0.404			Benign		rs1370273:rs1404883356		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.57														
chr15:80168182	SNV	A	1	G/G	PASS	0.0	3967.58		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.221	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.553+33A>G				G	GMAF=0.273:AMAF=0.2453:EMAF=0.2871			Benign		rs1545119		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.21														
chr15:80186247	MNV	ACCCC	5	CTTTG/CTTTG	PASS	0.0	3863.46		386	ACCCC=0,CTTTG=386	ACCCC=0.0,CTTTG=1.0	100.00	0.0	0	1	0.112	1		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*38ACCCC>CTTTG				CTTTG						rs3210172:rs1049181:rs374309326:rs751787251:rs370537299:rs199626920:rs377100715:rs369845634:rs386785740		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.95,0.27,0.04,0.13,0.06														
chr15:80186257	INDEL	AC	1	A/A	PASS	9.79489985408666e-276	2750.09		396	AC=0,A=396	AC=0.0,A=1.0	100.00	0.0	homozygous	1	0.112	3		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*48AC>A				A	GMAF=0.1042:AMAF=0.0643:EMAF=0.1249			Likely benign		rs200464452:rs755736456:rs749985438		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.97,0.39														
chr15:80186303	SNV	T	1	C/C	PASS	0.0	3935.32		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.113	2		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*94T>C				C				Benign		rs1049194		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.25														
chr16:71570009	SNV	C	1	C/A	PASS	1.125122992965752e-53	529.488		280	C=151,A=129	C=0.5393,A=0.4607	46.07	53.93	heterozygous	1	0.433	5		TAT|TAT-AS1	NM_000353.3|NR_103851.1	TAT:intronic:NM_000353.3|TAT-AS1:intronic_nc:NR_103851.1	unknown|	|	|	p.?|	c.1042-72G>T|	|	|	|	A|						rs172650:rs1413052063		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.63														
chr16:71573481	SNV	T	1	T/G	PASS	1.5484600317618007e-66	658.101		336	T=179,G=157	T=0.5327,G=0.4673	46.73	53.27	heterozygous	1	0.414	1		TAT	NM_000353.3	TAT:intronic:NM_000353.3	unknown			p.?	c.408+58A>C				G	GMAF=0.3121:AMAF=0.229:EMAF=0.3482					rs2432520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.9														
chr17:7221421	INDEL	ACTGCCCTAGGTCAGGAA	17	A/A	PASS	0.0	3363.98		336	ACTGCCCTAGGTCAGGAA=0,A=336	ACTGCCCTAGGTCAGGAA=0.0,A=1.0	100.00	0.0	homozygous	1	0.002	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-116_478-100delCTGCCCTAGGTCAGGAA				A						rs750835287:rs1567562754:rs80162838:rs78100429:rs535609436:rs35999860:rs147519793:rs1416225920:rs1184230081:rs1322109465:rs386795011:rs374828700:rs907034423:rs7503586:rs370388543:rs201760717:rs1031535036		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	-0.78,0.12,0.1,-0.17,-0.72,-1.03,-0.35,-0.01,-1.94,-0.18,1.36,-1.92,-0.66,0.83,-0.02,0.03,-0.03,-0.45														
chr17:7221449	SNV	T	1	C/C	PASS	0.0	3839.13		385	T=0,C=385	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.478	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-89T>C				C						rs77493353:rs1416225920:rs9646410:rs386795011:rs386795012:rs374828700:rs1567562793		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	0.0														
chr17:7224399	SNV	T	1	C/C	PASS	0.0	3706.07		382	T=3,C=379	T=0.0079,C=0.9921	99.21	0.7900000000000063	homozygous	1	0.48	1		ACADVL|DVL2	NM_000018.4|NM_004422.3	ACADVL:intronic:NM_000018.4|DVL2:downstream:NM_004422.3	unknown|unknown	|	|	p.?|p.?	c.1605+6T>C|c.*1466A>G	|	|	|	C|C	GMAF=0.4383:AMAF=0.4362:EMAF=0.3739	0.07		Benign	7228542.0	rs17671352:rs1064795676		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0016328:GO:0043507:GO:0016604:GO:0090179:GO:0061098:GO:0022007:GO:0051091:GO:0043621:GO:0007379:GO:0043547:GO:0004466:GO:0006635:GO:0033539:GO:0005109:GO:0045177:GO:0000062:GO:0048365:GO:0005829:GO:0031314:GO:0019901:GO:0019904:GO:0090103:GO:0150012:GO:0045334:GO:0090181:GO:0030855:GO:0005634:GO:0005515:GO:0005759:GO:0017099:GO:0034613:GO:0003151:GO:0005730:GO:0045944:GO:0005654:GO:0009409:GO:0007507:GO:0001843:GO:0044340:GO:0046322:GO:0031410:GO:0060070:GO:0060071:GO:0016235:GO:0045717:GO:0061024:GO:0042802:GO:0015980:GO:0006355:GO:1904886:GO:0042645:GO:0003995:GO:0090090:GO:0031966:GO:0050660:GO:0005737:GO:0001659:GO:0005739:GO:0001934:GO:0035329:GO:0030674:GO:0035567	609575:602151	PF02771:PF02770:PF00441:PF08028	-0.25														
chr19:12899706	SNV	A	1	G/G	PASS	0.0	3983.97		398	A=0,G=398	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.28	1		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:intronic:NM_001105578.2	|unknown	|	11|	|p.?	|c.612+298T>C	|	|	|	|G	GMAF=0.3611:AMAF=0.1756:EMAF=0.4546	0.11		Benign	7218541.0	rs8012		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF01442:PF00441:PF08028	0.32														
chr19:41397766	SNV	A	1	G/G	PASS	0.0	4002.77		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.418	3		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-438T>C|c.-62A>G	|	|	|	G|G						rs892044		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.08														
chr19:41397770	SNV	A	1	G/G	PASS	0.0	3988.0		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.02	1		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-442T>C|c.-58A>G	|	|	|	G|G						rs892043		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.12														
chr19:41397794	SNV	T	1	T/G	PASS	9.700631337839622e-83	820.132		400	T=209,G=191	T=0.5225,G=0.4775	47.75	52.25	heterozygous	1	0.082	1		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-466A>C|c.-34T>G	|	|	|	G|G	GMAF=0.1072:AMAF=0.0395:EMAF=0.1419			Likely benign		rs45500792		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		-0.43														
chr19:41414039	SNV	A	1	C/C	PASS	0.0	4003.01		400	A=0,C=400	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.384	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.376-10A>C				C	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.01		Benign	4000746.0	rs3213861		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.51														
chr19:41422431	SNV	T	1	C/C	PASS	0.0	3557.08		360	T=1,C=359	T=0.0028,C=0.9972	99.72	0.28000000000000114	homozygous	1	0.382	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.853+61T>C				C						rs284651		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-2.12														
chr19:41422747	SNV	C	1	T/T	PASS	0.0	3929.35		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.384	2		BCKDHA	NM_001164783.2	BCKDHA:exonic:NM_001164783.2	synonymous	TTT	7	p.Phe323=	c.969C>T				T	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.92		Benign	3933055.0	rs284652:rs112312448		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	2.87														
chr19:41422819	SNV	G	1	A/A	PASS	0.0	3935.15		400	G=2,A=398	G=0.005,A=0.995	99.50	0.5	homozygous	1	0.414	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+49G>A				A	GMAF=0.3565:AMAF=0.2855:EMAF=0.3929			Benign/Likely benign		rs284654		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-1.91														
chr19:41422860	SNV	C	1	T/T	PASS	0.0	4003.3		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.386	2		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+90C>T				T						rs284655		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	0.58														
chr19:41424491	SNV	A	1	G/G	PASS	0.0	3679.33		368	A=0,G=368	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.383	1		BCKDHA|B3GNT8	NM_001164783.2|NM_198540.2	BCKDHA:exonic:NM_001164783.2|B3GNT8:downstream:NM_198540.2	synonymous|unknown	CTG|	9|	p.Leu406=|p.?	c.1218A>G|c.*1094T>C	|	|	|	G|G	GMAF=0.323:AMAF=0.1895:EMAF=0.3914	0.15		Benign	7239888.0	rs4674		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0009083:GO:0016758:GO:0008375:GO:0006486:GO:0008532:GO:0000139:GO:0005794:GO:0008376:GO:0003863:GO:0005515:GO:0070062:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0016262:GO:0016021:GO:0055114:GO:0016266:GO:0030311:GO:0016831	615357:608348	PF00676	0.76														
chr19:45529583	SNV	G	1	G/C	PASS	2.9093769918965885e-97	965.362		399	G=193,C=206	G=0.4837,C=0.5163	51.63	48.37	heterozygous	1	0.309	4		OPA3																	rs12971437		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)			606580		-0.72														
chr19:45553823	SNV	A	1	G/G	PASS	0.0	4003.23		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.233	1		OPA3	NM_025136.4	OPA3:exonic:NM_025136.4	synonymous	GCC	2	p.Ala77=	c.231T>C				G	GMAF=0.3174:AMAF=0.2398:EMAF=0.3572	0.09		Benign	439792.0	rs3826860		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580	PF07047	-0.93														
chr19:51347036	SNV	G	1	G/A	PASS	7.992819398621687e-76	750.973		399	G=216,A=183	G=0.5414,A=0.4586	45.86	54.14	heterozygous	1	0.42	1		ETFB	NM_001985.3	ETFB:exonic:NM_001985.3	missense	ATG	5	p.Thr154Met	c.461C>T	0.01	0.98	81.0	A	GMAF=0.4582:AMAF=0.4911:EMAF=0.4413	0.94		Benign	3721676.0	rs1130426		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	3.13														
chr19:51347231	SNV	T	1	T/C	PASS	3.0521087222420106e-72	715.154		400	T=221,C=179	T=0.5525,C=0.4475	44.75	55.25	heterozygous	1	0.456	5		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.439-173A>G				C				Benign		rs8112785		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-0.49														
chr19:51354360	INDEL	T	1	T/TG	PASS	0.0029172254922429	25.3503		342	T=238,TG=104	T=0.6959,TG=0.3041	30.41	69.59	heterozygous	1	0.024	5		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.58-53_58-52insC				TG	GMAF=0.0324:AMAF=0.008:EMAF=0.0451			Benign		rs74357706:rs141529162		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-0.65														
chr19:51366234	SNV	G	1	G/C	PASS	4.402506440739085e-96	953.563		366	G=169,C=197	G=0.4617,C=0.5383	53.83	46.17	heterozygous	1	0.002	3		ETFB|CLDND2	NM_001985.3|NM_152353.3	ETFB:intronic:NM_001985.3|CLDND2:downstream:NM_152353.3	unknown|unknown	|	|	p.?|p.?	c.57+36C>G|c.*908C>G	|	|	|	C|C	GMAF=0.002:AMAF=0.0059:EMAF=0.0					rs186691166		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904:GO:0016021:GO:0005886	130410	PF01012	0.97														
